AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10614892
Drug: Computer-assisted management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-assisted management of warfarin therapy
Trial: 15449753
Drug: Morphine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (1 mg/kg)
Trial: 30301252
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of SRS and ICIs
Trial: 26997655
Drug: Low-dose VPA
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose VPA (800 mg/day)
Trial: 26997655
Drug: High-dose VPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose VPA (1200 mg/day)
Trial: 24586256
Drug: TRC150094 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRC150094 (50 mg once daily)
Trial: 20061421
Drug: GH +
RxNorm normalized name: Delsym Cough + Cold Daytime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH + Ox 0.03 mg/kg . d
Trial: 11692346
Drug: Placebo (water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (water spray)
Trial: 2239934
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (r‐HuEPO) therapy for 18 +/- 6 weeks
Trial: 27867128
Drug: Meropenem 2
RxNorm normalized name: meropenem 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem 2 g every 8 hours
Trial: 16555941
Drug: 375 ml
RxNorm normalized name: isopropyl alcohol 0.0375 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 375 ml of white wine daily
Trial: 9692103
Drug: Amoxycillin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin (500 mg t.d.s.)
Trial: 3167404
Drug: Clomipramine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine treatment with self-exposure instructions
Trial: 20388201
Drug: Taxane-based chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taxane-based chemotherapy (Carboplatin AUC5 and Docetaxel 75 mg/m2 administered intravenously in a 3-weekly schedule)
Trial: 16840728
Drug: Intensive induction
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive induction and consolidation treatment according to a single protocol for patients above age 60
Trial: 14564333
Drug: Heparin-coated stent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated stent
Trial: 1631174
Drug: Potassium depletion
RxNorm normalized name: Potassium
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium depletion treatment (KD0, KD1, KD2)
Trial: 1631174
Drug: Potassium depletion
RxNorm normalized name: Potassium
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium depletion treatment (KD2)
Trial: 6386253
Drug: Dihydroquinidine (DQ)
RxNorm normalized name: Hydroquinidine
DrugBank: Hydroquinidine (DB15300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroquinidine (DQ) 300 mg t.i.d.
Trial: 6386253
Drug: Disopyramide (D)
DrugBank: Disopyramide (DB00280)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disopyramide (D) 200 mg t.i.d.
Trial: 30672383
Drug: rs3842761 GG/CC+CG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rs3842761 GG/CC+CG in FIGO stage III‐IV
Trial: 25266206
Drug: High-protein yogurt
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-protein yogurt (14 g protein/25 g CHO/0 g fat)
Trial: 15337553
Drug: Oral aloe
RxNorm normalized name: Aloe
DrugBank: Aloe ferox leaf (DB14257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral aloe vera gel
Trial: 2642754
Drug: Probucol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probucol (500 mg b.i.d.)
Trial: 2642754
Drug: Lovastatin plus
RxNorm normalized name: Lovastatin
DrugBank: Lovastatin (DB00227)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lovastatin plus colestipol (10 g b.i.d.)
Trial: 2642754
Drug: Lovastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin (80 mg/day) plus colestipol (10 g b.i.d.)
Trial: 10394450
Drug: Water administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water administration
Trial: 17697100
Drug: Cholinesterase inhibitor
RxNorm normalized name: Acetylcholinesterase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholinesterase inhibitor therapy (ChEI)
Trial: 14995919
Drug: Acupuncture (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture (n = 37), stimulated once or twice a week until delivery or complete recovery
Trial: 11994555
Drug: GPIIb/IIIa antagonist,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GPIIb/IIIa antagonist, orbofiban
Trial: 2334579
Drug: Tranquilizer (clobazam)
RxNorm normalized name: Clobazam
DrugBank: Clobazam (DB00349)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranquilizer (clobazam)
Trial: 30137547
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations (MR and IR)
Trial: 18815438
Drug: Mixed amphetamine
RxNorm normalized name: mixed amphetamine salts 5 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed amphetamine salts-extended release (MAS XR) 50 mg/day
Trial: 22519922
Drug: Atomoxetine 80
RxNorm normalized name: atomoxetine 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine 80 mg/day
Trial: 16021360
Drug: 250 mcg
RxNorm normalized name: Nplate 250 MCG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mcg IFNbeta‐1b every other day
Trial: 2618318
Drug: Halothane inhalation
RxNorm normalized name: Halothane Inhalation Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Halothane inhalation anaesthesia in combination with nitrous oxide and oxygen
Trial: 383272
Drug: 100 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/m2 q 3 wk
Trial: 383272
Drug: 200 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/m2 q 6 wk
Trial: 25671254
Drug: Lenvatinib (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenvatinib (24 mg per day in 28-day cycles)
Trial: 22559867
Drug: 0.005% latanoprost
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.005% latanoprost once daily
Trial: 8743003
Drug: 0.5% timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% timolol twice daily
Trial: 1996894
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg daily for six days
Trial: 1996894
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg every 12 hours for three doses
Trial: 17086021
Drug: Hydrochlorothiazide 25
RxNorm normalized name: hydrochlorothiazide 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 25 mg/d
Trial: 6648735
Drug: Hydrochlorothiazide 25
RxNorm normalized name: hydrochlorothiazide 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 25 mg plus triamterene 50 mg
Trial: 6648735
Drug: Amiloride hydrochloride
RxNorm normalized name: Amiloride Hydrochloride
DrugBank: Amiloride (DB00594)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amiloride hydrochloride 5 mg plus hydrochlorothiazide 50 mg
Trial: 6648735
Drug: Chlorthalidone 50
RxNorm normalized name: chlorthalidone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 50 mg/d
Trial: 6873133
Drug: Indapamide 2.5
RxNorm normalized name: indapamide 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indapamide 2.5 mg/d
Trial: 30792142
Drug: Iron-rich meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-rich meal (43 mg of iron)
Trial: 25544294
Drug: Lidocaine plus
RxNorm normalized name: Icy Hot Lidocaine Plus Menthol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine plus dexmedetomidine solution
Trial: 25544294
Drug: Lidocaine solution
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine solution
Trial: 21443422
Drug: Acetyl-L-carnitine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine (2 g twice a day for 90 days)
Trial: 8527290
Drug: Itraconazole 100
RxNorm normalized name: itraconazole 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 100 mg
Trial: 15319645
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (triple treatment and placebo)
Trial: 17714334
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin (BTX) treatment
Trial: 9173954
Drug: CHO supplement
RxNorm normalized name: G-CSF (CHO cell derived)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO supplement (1 g/kg) immediately postexercise
Trial: 9173954
Drug: CHO supplement
RxNorm normalized name: G-CSF (CHO cell derived)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO supplement (1 g/kg) 1 h postexercise
Trial: 3099002
Drug: Complex and
RxNorm normalized name: vitamin B complex and C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex and elemental enteral formulas at infusion rates of 50 to 150 kcal/hr
Trial: 28728683
Drug: Conventional HF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional HF treatment combined with an individualized nutritional intervention
Trial: 28728683
Drug: Conventional HF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional HF treatment
Trial: 22094904
Drug: BMMSC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMMSC treatment and CD treatment
Trial: 12692844
Drug: p53 immunostaining
FDA approved: no
EMA approved: no
PMDA approved: no
Description: p53 immunostaining (using mouse monoclonal antibody pAb1801)
Trial: 1516415
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg tablets, three times daily for 48 hours prior to testing)
Trial: 3523041
Drug: Postoperatively administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperatively administered plasma proteins
Trial: 22237175
Drug: Cytomegalovirus therapeutic
RxNorm normalized name: cytomegalovirus immunoglobulin
DrugBank: Human cytomegalovirus immune globulin (DB13886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytomegalovirus therapeutic DNA vaccine (TransVax) administered before conditioning and at 1, 3, and 6 months after transplantation.
Trial: 19292590
Drug: lopinavir/ritonavir monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lopinavir/ritonavir monotherapy
Trial: 8830827
Drug: rhuIL‐1R therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhuIL‐1R therapy
Trial: 3910302
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (TU) 40 mg/d
Trial: 3910302
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (TU) 80 mg/d
Trial: 3910302
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (TU) 120 mg/d
Trial: 23945510
Drug: Intranasal dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal dexmedetomidine 1 μg/kg
Trial: 23812579
Drug: Prolapse surgery
RxNorm normalized name: Prolate
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prolapse surgery with concurrent tension-free vaginal tape (TVT)
Trial: 20138267
Drug: AMH level
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMH level ≥3.01 ng/mL
Trial: 20138267
Drug: AMH level
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMH level ≥3.2 ng/mL
Trial: 11888456
Drug: Hypoventilation (tidal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypoventilation (tidal volume 4 mL/kg, respiratory rate 15/min)
Trial: 11888456
Drug: Normoventilation (tidal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normoventilation (tidal volume 10 mL/kg, respiratory rate 10/min)
Trial: 9861280
Drug: Mectizan (ivermectin)
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mectizan (ivermectin) treatment every 3 months
Trial: 9861280
Drug: Mectizan (ivermectin)
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mectizan (ivermectin) treatment every 6 months
Trial: 9861280
Drug: Mectizan (ivermectin)
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mectizan (ivermectin) treatment every 12 months
Trial: 9861280
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment every 3 months
Trial: 342174
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose fenoterol (5.6 microgram)
Trial: 342174
Drug: Medium dose
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium dose fenoterol (32.7 microgram)
Trial: 342174
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose fenoterol (127.5 microgram)
Trial: 28133906
Drug: Tacrolimus-based therapy
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus-based therapy
Trial: 23682170
Drug: Walking training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Walking training including balance exercises and lower limb strength activities twice a week for 4 months
Trial: 20704266
Drug: Bead formulation
RxNorm normalized name: Beads
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bead formulation with faster dissolution rate (80% dissolved in 41 min)
Trial: 20704266
Drug: Bead formulation
RxNorm normalized name: Beads
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bead formulation with slower dissolution rate (80% dissolved in 114 min)
Trial: 10665727
Drug: Miller‐Galante II
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miller‐Galante II (MG II)
Trial: 29665620
Drug: Anti-inflammatory nutrition
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-inflammatory nutrition supplement (AINS) consisting of long chain n-3 PUFA, vitamin C, α-tocopherol, green tea extract, and lycopene for 8 weeks
Trial: 12225705
Drug: Placebo nicotine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo nicotine nasal spray
Trial: 15914133
Drug: Suppository
RxNorm normalized name: Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suppository
Trial: 20739719
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (NaHCO₃) 0.3 g/kg body weight
Trial: 10506264
Drug: Acetaminophen (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (12 mg/kg)
Trial: 29140929
Drug: Sham injection
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham injection (nocebo pain)
Trial: 25524125
Drug: Dermal patch
RxNorm normalized name: TRANSDERMAL PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermal patch (control)
Trial: 21872244
Drug: 600 μg
RxNorm normalized name: P.G. 600 KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 μg of oral misoprostol
Trial: 19485583
Drug: Supervisor focus
RxNorm normalized name: Ficus benghalensis bark extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervisor focus on adherence to treatment principles
Trial: 17214933
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese herbal medicine (CM) including Glucosidorum Tripterygii Totorum Tablet and syndrome differentiation treatment
Trial: 17214933
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (WM) including voltaren extended action tablet, methotrexate, and sulfasalazine
Trial: 11319627
Drug: Active Ma
RxNorm normalized name: OCTINOXATE .012 mL in 6 mL / OCTISALATE .12 mL in 6 mL TOPICAL CREAM [RIMMEL LONDON MOISTURE RENEW LIPGLOSS - ACTIVE MAUVE (135)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active Ma Huang/Guarana (72 mg/day ephedrine alkaloids and 240 mg/day caffeine)
Trial: 24075206
Drug: Less Invasive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Less Invasive Surfactant Administration (LISA)
Trial: 19083472
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein (WY) 15 g
Trial: 19083472
Drug: Essential amino
RxNorm normalized name: Essential amino acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essential amino acids (EAA) 6.72 g
Trial: 19083472
Drug: Nonessential amino
RxNorm normalized name: Nonessential amino acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonessential amino acids (NEAA) 7.57 g
Trial: 16510062
Drug: Topical allylamine
RxNorm normalized name: vanillylamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical allylamine antifungals (naftifine, terbinafine, butenafine)
Trial: 16510062
Drug: Topical azole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical azole antifungals (clotrimazole, econazole, ketoconazole, oxiconazole, miconazole, sulconazole)
Trial: 10894274
Drug: Lamivudine therapy
RxNorm normalized name: Lamivudine
DrugBank: Lamivudine (DB00709)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lamivudine therapy for 44-52 weeks
Trial: 1376362
Drug: Hydromorphone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone (5 and 10 mg)
Trial: 28841028
Drug: Pre-hospital ticagrelor
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-hospital ticagrelor treatment
Trial: 28969431
Drug: HIV-DNA 600
RxNorm normalized name: TOXOPLASMA GONDII DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV-DNA 600 μg (n=10)
Trial: 28969431
Drug: HIV-DNA 1200
RxNorm normalized name: TOXOPLASMA GONDII DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV-DNA 1200 μg (n=10)
Trial: 24295662
Drug: Combined modality
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined modality using chemotherapy and concurrent radiation
Trial: 23154315
Drug: Self-administered paper
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered paper interview
Trial: 2145744
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (no thrombolytic therapy)
Trial: 28063938
Drug: BCV 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCV 100 mg (2 mg/kg if <50 kg) twice weekly (BIW)
Trial: 28063938
Drug: BCV 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCV 200 mg (4 mg/kg if <50 kg) once weekly (QW)
Trial: 19706085
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide 0.01% oil applied twice daily for 4 weeks
Trial: 7805700
Drug: Piroxicam beta‐cyclodextrin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam beta‐cyclodextrin (tablet and sachet formulations)
Trial: 3815764
Drug: Taurine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taurine (6 g for 7 days)
Trial: 12668787
Drug: Combined inhalation
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined inhalation of nitric oxide and oxygen
Trial: 7548496
Drug: Ciprofloxacin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (250 mg once a day for 3 days)
Trial: 7548496
Drug: Tetracycline (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracycline (500 mg four times a day for 3 days)
Trial: 1940257
Drug: Silibinin 100
RxNorm normalized name: Silibinin
DrugBank: Silibinin (DB09298)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silibinin 100 mg/kg body weight i.p. for 7 days
Trial: 1940257
Drug: Silibinin 50
RxNorm normalized name: Silibinin
DrugBank: Silibinin (DB09298)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silibinin 50 mg/kg body weight i.p. for 7 days
Trial: 28106354
Drug: Ropivacaine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine (20 mL of 0.5%) + Dexmedetomidine (1 µg/kg)
Trial: 28106354
Drug: Ropivacaine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine (20 mL of 0.5%)
Trial: 17033146
Drug: Evidence-based medicine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based medicine (EBM)
Trial: 11680444
Drug: Estradiol therapy
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol therapy (1 mg of estradiol-17beta per day)
Trial: 30304656
Drug: Delayed strategy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed strategy for renal-replacement therapy (after a delay of 48 hours if renal recovery had not occurred)
Trial: 30304656
Drug: Delayed strategy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed strategy for renal-replacement therapy
Trial: 17017821
Drug: Selegiline transdermal
RxNorm normalized name: Selegiline Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline transdermal system (STS) 6 mg/24 hours to 12 mg/24 hours